A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Clare Twist, MD
Roswell Park Comprehensive Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital for Sick Children
Toronto, Ontario, Canada
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Lucile Packard Children'S Hospital at Stanford University Medical Center
Palo Alto, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S National
Washington D.C., District of Columbia, United States
- University of Florida
Gainesville, Florida, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Ann and Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
- Memorial Sloan Kettering
New York, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Upmc Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Texas Children'S Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jul 2022
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2027
- Last update posted
- 2 Jun 2026
- Registered enrollment
- 35
- Registry id
- NCT04978727
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.